Handelsbanken Fonder
EDIT icon

Handelsbanken Fonder’s Editas Medicine EDIT Stock Holding History

Handelsbanken Fonder’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,400
Closed -$119K – 1589
2023
Q1 		$119K Hold
16,400
– – ﹤0.01% 1520
2022
Q4 		$145K Hold
16,400
– – ﹤0.01% 1478
2022
Q3 		$201K Hold
16,400
– – ﹤0.01% 1435
2022
Q2 		$194K Hold
16,400
– – ﹤0.01% 1500
2022
Q1 		$312K Hold
16,400
– – ﹤0.01% 1495
2021
Q4 		$435K Hold
16,400
– – ﹤0.01% 1445
2021
Q3 		$674K Hold
16,400
– – ﹤0.01% 1141
2021
Q2 		$929K Buy
16,400
+5,800
+55% +$214K ﹤0.01% 965
2021
Q1 		$445K Buy
10,600
+1,200
+13% +$68.4K ﹤0.01% 1255
2020
Q4 		$659K Hold
9,400
– – ﹤0.01% 1009
2020
Q3 		$264K Hold
9,400
– – ﹤0.01% 1299
2020
Q2 		$278K Buy
+9,400
New +$246K ﹤0.01% 1260
2019
Q1 		– Sell
-135,000
Closed -$3.07M – 185
2018
Q4 		$3.07M Hold
135,000
– – 0.06% 150
2018
Q3 		$4.3M Buy
135,000
+15,000
+13% +$485K 0.08% 152
2018
Q2 		$4.3M Buy
+120,000
New +$4.25M 0.08% 151

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Handelsbanken Fonder's EDIT Position: Q2 2023 in Review

Handelsbanken Fonder sold out of Editas Medicine (EDIT) in Q2 2023, closing a stake of 16,400 shares — an estimated $119K sold.

Handelsbanken Fonder first reported a position in EDIT in Q2 2018 and held it in 15 quarters. The position peaked at $4.3M in Q2 2018. 238 funds tracked by Wall St. Rank hold EDIT as of Q2 2023.

  • Handelsbanken Fonder reported no remaining Editas Medicine position as of Q2 2023 after selling out during the quarter.
  • Handelsbanken Fonder sold 16,400 Editas Medicine shares in Q2 2023, an estimated $119K.
  • Handelsbanken Fonder first reported a position in Editas Medicine in Q2 2018 and held it in 15 quarters.
  • Handelsbanken Fonder's Editas Medicine position peaked at $4.3M in Q2 2018.
  • 238 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2023.

Based on Handelsbanken Fonder's 13F filing for Q2 2023, filed 2 Aug 2023.